EU Health Experts On How ‘Optimization’ Could Improve Benefit Of New Cancer Drugs
EU health policy experts including the European Medicines Agency’s Emer Cooke discuss ways to optimize the use of innovative cancer medicines, given that many new drugs fail to offer notable clinical benefits compared to existing therapies.
